Warfarin resistance in a patient with prosthetic valve endocarditis treated with cloxacillin

Saudi Pharmaceutical Journal

Volumn 4, Issue 1, 1996, Pages 56-59

  Ibrahim, Osama M ^a   Allam, Abdulkader ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

cloxacillin; drug interaction; endocarditis; resistance; warfarin

Indexed keywords

AMOXICILLIN; AMPICILLIN; CLOXACILLIN; DICLOXACILLIN; ERYTHROMYCIN; FUSIDIC ACID; HEPARIN; NAFCILLIN; PENICILLIN G; VANCOMYCIN; WARFARIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CLOTTING; DRUG RESISTANCE; DRUG THERAPY; ENDOCARDITIS; PROSTHESIS;

EID: 0029985590     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. David S. Tatro (Ed.). Drug Interaction Facts. , St. Louis, Missouri: Wolters Kluwer Company, Facts and Comparisons, January 1995; 39-110.
2. Talstad I, Gamst ON. Warfarin resistance due to malabsorption. J Intern Med, 1994; 236(4):465-7.
3. Kearns PJ. Jr, O'Reilly RA. Bioavailability of warfarin in a patient with severe short bowel syndrome. JPEN-J-Parenter-Enteral-Nutr, 1986; 10(1): 100-1.
4. Lutomski DM, Palascak JE, Bower RH. Warfarin resistance associated with lipid administration. (JPEN)-J-Parenter-Enteral-Nutr, 1987; 11(3):316-8.
5. Howard PA, Hannaman KN. Warfarin resistance linked to enternal nutrition products. J Am Diet Assoc 1985; 85(6): 713-5.
6. Landau J, Moulda RF. Warfarin resistance caused by vitamin K in intestinal feeds (letter). Med J Aust, 1982; 2(5):263-4.
7. Zallman JA, Lee DP, Jeffrey PL. Liquid nutrition as a cause of warfarin resistance. Am J Hosp Pharm, 1981; 38(8)1174.
8. Shovick VA, Rihn TL. Decreased hypoprothrombinic response to warfarin secondary to the warfarin-nafcillin interaction. DICP, 1991; 25(6):598-600.
9. Qureshi GD, Reinders TP, Somori GJ, Evans HJ. Warfarin resistance with nafcillin therapy. Ann Intern Med, 1984; 100(4):527-9.
10. Taylor AT, Pritchard DC, Goldstein AO. Continuation of warfarin-nafcillin interaction during dicloxacillin therapy. The J of Family Practice, 1994; 39(2):182-5.
11. Krstenansky PM, Jones WN, Garewal HS. Effect of dicioxacillin sodium on the hypoprothrombinemic response to warfarin sodium. Clin Pharmacy, 1987; 6:804-6.
12. Fraser G L, Miller M, Kane K. Warfarin resistance associated with nafcillin therapy. Am J Med, 1989; 87(2) :237-8.
13. Zahger D, Maaravi Y, Matzner Y, Gilon D, Gotsman MS, Weiss AT. Partial resistance to anticoagulation after streptokinase treatment for acute myocardial infarction. Am J Cardiol, 1990:28-30.
14. Kumar S, Haigh JR, Davies JA, Roberts BE, Feely MP. Apparent warfarin resistance due to poor compliance. Clin Lab Haematol 1989; 11(2):161-3.
15. Kempin SJ. Warfarin resistance caused by brocoli (letter). NEJM, 1983; 308(20):1229-30.
16. Qureshi GD, Reinders TP, Swint JJ, Slate MB. Acquired warfarin resistance and weight-reducing diet. Arch Intern Medicine, 1981; 141(4):507-9.
17. Diab F, Feffer S. Hereditary warfarin resistance. South Med J, 1994; 87(3):407-9.
18. Warrier I, Brennan CA, Lusher JM. Familial warfarin resistance in a black child. Am J Pediatr Hemalol Oncol, 1986 Winter; 8(4):346-7.
19. Holt RJ, Freytes CO. Familial warfarin resistance. DICP, 1983; 17(4):281-3.
20. Alving BM, Strickler MP, Knight RD, Barr CF, Berenberg JL, Peck CC. Hereditary warfarin resistance investigation of a rare phenomenon. Arch Intern Med, 1985; 11(3): 145-58.
21. O'reilly RA. The second reported kindred with hereditary resistance to oral anticoagulant drugs. NEJM, 1970; 282 (26):1448-51.